Larry Weiner

About Larry Weiner

Larry Weiner is a biopharma leader with >30 years of Operations and Management experience. I am passionate about leadership development, teamwork, organization culture, project/program management, risk-based decision making, and strategy development & successful execution. Current and previous roles include broad responsibility for Manufacturing, CMC, Program Management, Supply Chain, Project Management, Facilities and Engineering. Larry leads Manufacturing, Engineering and CMC operations at the regenerative medicine division of Sumitomo Pharma America (formerly Enzyvant Therapeutics). Larry led Technical Operations at Unum Therapeutics and Late Stage Program Management and Real Estate & Facilities operations at Indigo. As the Senior Director of Strategic Programs and Program Management at Biogen, innovation program responsibilities included leading drug substance, drug product, device, and new technology innovation initiatives that addressed significant business opportunities and/or were disruptive to the industry. Led the teams that established Biogen\'s gene therapy, oligonucleotide, and drug product operations strategies. Program management responsibilities included CMC, new product launches, and supply chain support for clinical and commercial therapeutic assets. Additional responsibilities included resource planning and operations portfolio management.Experience includes engineering & facilities operations, capital project management, process development, manufacturing, innovation, engineering and management positions of increasing responsibility at Amgen, Serono Laboratories, Wyeth, MassBiologics, Biogen, Indigo, Unum, and Enzyvant. Larry has a BS Ch.E. from Tufts University, MBA in Operations & Finance from Babson College, and a Masters in Bioengineering from Tufts. Executive Certificates include Operations & Value Chain Management (MIT) and Drug Development (Harvard). Professional interests include delivering results, enabling innovation, developing people, creating sustainable systems, and creating high-performance teams. Personal interests include sailing, fitness, travel, sports, and family.

Experience

1. Member Board of Directors

   Sunflower Therapeutics

   Sep 2022 — Present · Medford, MA, US

Education

• MIT Sloan School of Management

  Executive Certificate, Technology, Operations & Value Chain Management

  2010 — 2011

• Tufts University

  B.S. Ch.E., Chemical Engineering

  1985 — 1989

• Tufts University

  Master’s Degree, Chemical & Biological Engineering

  2011 — 2016

• Harvard University

  Executive Certificate in Drug Development

  2016 — 2016

• Babson F.W. Olin Graduate School of Business

  MBA, Management & Finance

  1996 — 2001

Skills

• Biopharmaceuticals
• Manufacturing
• U.s. Title 21 Cfr Part 11 Regulation
• Technology Transfer
• U.s. Food and Drug Administration (Fda)
• Pharmaceutical Industry
• Fda
• Gmp
• Biotechnology
• Leadership
• Change Control
• Medical Devices
• Capa
• 21 Cfr Part 11
• Cross-Functional Team Leadership
• Quality System
• V&V
• Process Simulation
• Verification and Validation (V&V)
• Validation
• Engineering